Uncategorized

2020 Presenting Companies Transactions

ArcScan, Inc.

Presented at ACCESS CHINA Winter event 2020

July 31, 2021- ArcScan, Inc. announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological that will result in a $11.15 million Preferred Series B investment into ArcScan, Inc. ArcScan, Inc. will help Haohai further develop their rapidly expanding offering of implantable lenses.

ImmuneOncia Therapeutics, Inc.

Presented at ACCESS CHINA Summer event 2020

March 31, 2021- ImmuneOncia Therapeutics, Inc. signs exclusive license agreement with 3D Medicines, Inc. for the development, manufacture, and commercialization of IMC-002. The agreement includes uses of IMC-002 for oncology indication as a monotherapy or combination agent in the Territory of Greater China. 

AUM Biosciences

Presented at ACCESS CHINA Spring event 2020

November 18, 2020- AUM Biosciences and Newsoara Biopharma announce a 5-year transformational Strategic Partnership to co-develop and co-discover Next-Generation Cancer Therapeutics. AUM will license exclusive greater China rights of AUM001, AUM302 and AUM003, and up to a further 3 candidates for a maximum of 6 oncology drugs.

Starton Therapeutics

Presented at ACCESS CHINA Spring event 2020

March 1, 2021- Starton Therapeutics entered into an exclusive licensing agreement for the development and commercialization of STAR-OLZ in Mainland China with Haisco Pharma. STAR-OLZ is a once-weekly transdermal delivery system for chemotherapy induced nausea and vomiting and PARP inhibitor induced nausea and vomiting.

Rhizen Pharmaceuticals

Presented at ACCESS CHINA Spring event 2020

October 31, 2020- Rhizen Pharmaceuticals signs exclusive license agreement with Curon Biopharma for the development and commercialization of Tenalisib in Greater China. Tenalisib (RP6530) is a highly selective, next-generation, orally active, dual PI3K delta and gamma inhibitor, that is currently in Phase 2 clinical development for hematological malignancies.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s